Skip Navigation

University of Kentucky: Dataset Details, ID=GSE161848

Superfund Research Program

Responsive Membranes and Advanced Materials for Sensing and Remediation of Halo-Organics

Project Leader: Dibakar Bhattacharyya
Co-Investigators: James Zach Hilt, Thomas Dean Dziubla, Isabel Escobar, Lindell E. Ormsbee
Grant Number: P42ES007380
Funding Period: 2020-2025
View this project in the NIH Research Portfolio Online Reporting Tools (RePORT)

Project-Specific Links

Connect with the Grant Recipients

Visit the grantee's eNewsletter page Visit the grantee's Twitter page Visit the grantee's Video page

Title: An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer’s disease

Accession Number: GSE161848

Link to Dataset: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE161848

Repository: Gene Expression Omnibus (GEO)

Data Type(s): Gene Expression

Experiment Type(s): Expression profiling by array

Organism(s): Mus musculus

Summary: Neuroinflammation has been increasingly recognized to play a critical role in Alzheimer’s disease (AD). The epoxy fatty acids (EpFAs) are derivatives of the arachidonic acid metabolism pathway and have anti-inflammatory activities. However, their efficacy is limited due to their rapid hydrolysis by the soluble epoxide hydrolase (sEH). We report that sEH is predominantly expressed in astrocytes and its concentrations are elevated in postmortem brain tissue from AD patients and in the 5xFAD -amyloid mouse model of AD. The amount of sEH expressed in AD mouse brains correlated with a reduction in brain EpFA concentrations. Using a specific small molecule sEH inhibitor, 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), we report that TPPU treatment protected AD mice against LPS-induced inflammation in vivo. Long-term administration of TPPU to the 5xFAD mouse model via drinking water reversed microglia and astrocyte reactivity and immune pathway dysregulation. This was associated with reduced β-amyloid pathology and improved synaptic integrity and cognitive function on two behavioral tests. Importantly, TPPU treatment correlated with an increase in EpFA concentrations in the brains of 5xFAD mice, demonstrating brain penetration and target engagement. These findings support further investigation of TPPU as a potential therapeutic agent for the treatment of AD.

Publication(s) associated with this dataset:
  • Meragawi SE, Akbari A, Hernandez S, Sharifzadeh Mirshekarloo M, Bhattacharyya D, Tanksale A, Majumder M. 2020. Enhanced permselective separation of per-fluorooctanoic acid in graphene oxide membranes by a simple PEI modification. J Mater Chem 12:17. doi:10.1126/scitranslmed.abb1206 PMID:33298560
Back
to Top